Biosecurity issues in synthetic biology have many stakeholders with different perspectives, including the biotechnology industry, academics, government officials. and members of the public.
DIY CRISPR kits are under the US Food and Drug Administration's (FDA) jurisdiction, but the FDA has not yet enforced any standards for biohackers.
California passes a law that will require sellers of DIY gene editing kits to display a warning that states the kits are not intended for use on the buyer.
What’s controversial about this research is that unlike gene therapies that alter the genes of adults to treat an inherited disease, this research attempts to alter germline DNA.
Individual scientists and scientific societies have called for a moratorium on heritable genome editing in humans, but a moratorium raises the question of when does the moratorium end.
China had regulations against germline editing when the scientist edited two female embryos genes using CRISPR to make them (theoretically) resistant to HIV infection.
The bill proposes to close a loophole in US law that allows dangerous toxins and agents to be knowingly accumulated by individuals without registration.
The biotechnology safety regulations focus on preventing bioterrorism, activities that violate ethics, along with avoiding biosafety hazards.
A Russian molecular biologist says he is planning to produce gene-edited babies, acting against the current scientific consensus that such experiments should be banned until an international ethical framework has agreed on the circumstances and safety measures.
This report providees researchers and government officials with an understanding of how ethics are created, monitored, and enforced across scientific disciplines and across borders.